USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
DELTAGEN PROTEOMICS, INC.
Address:
DELTAGEN PROTEOMICS, INC.
615 ARAPEEN DR, STE 300
SALT LAKE CITY, UT 84108
Phone:
(801) 303-0300
URL:
N/A
EIN:
870560505
DUNS:
N/A
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $384,487.00 4

Award List:

TRANSDOMINANT GENETICS IN WHOLE PLANTS

Award Year / Program / Phase:
1999 / SBIR / Phase I
Award Amount:
$85,813.00
Agency:
HHS
Principal Investigator:
Robert W. Sandrock
Abstract:
Not Available Over the past several years the Synthetic Environment Database Representation and Interchange Specification (SEDRIS) project has been developed to address the issues of simulation data interchange between heterogeneous applications in a non-ambiguous, lossless fashion. As one of the… More

N/A

Award Year / Program / Phase:
2000 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Tanya M. Sandrock
Abstract:
N/a

DOMINANT PEPTIDE INHIBITORS OF PLANT VIRUS REPLICATION

Award Year / Program / Phase:
2001 / SBIR / Phase I
Award Amount:
$99,174.00
Agency:
HHS
Principal Investigator:
Robert W. Sandrock
Abstract:
DESCRIPTION (Verbatim from Applicant's Abstract):We have developed a technology for somatic cell genetics that leads rapidly to genetic agents that modulate cellular phenotypes. The technology utilizes genetic assays in combination with perturbagens, peptides that inhibit specific… More

GLUTAMINE:FRUCTOSE-6-PHOSPHATE AMIDOTRANSFERASE FORNIDDM

Award Year / Program / Phase:
2002 / SBIR / Phase I
Award Amount:
$99,500.00
Agency:
HHS
Principal Investigator:
Abstract:
We have developed a transdominant genetic methodology for isolating peptide, protein or RNA factors (collectively called peturbagens) that modulate biochemical targets within a cell to alter its phenotype. Because it is genetic approach, it can be applied in both the classical forward mode (from… More